🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

Recruitingn/aAges 18 Years - anyAllGroupe Francophone des Myelodysplasies
NCT06956755 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male or female * Age \> 18 years * Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia * Able and willing to provide written informed consent Exclusion Criteria: * Age \<18 years * Patient is unwilling or unable to give consent
💊

What it tests

  • Not listed
📍

Where

1 site
Aspasia Stamatoullas
Rouen, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy